Verition Fund Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Verition Fund Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-67,549	Closed	-$3.49M	–	3215
2022 Q3	$3.49M	Buy	+67,549	New	+$2.79M	0.04%	597
2021 Q3	–	Sell	-26,710	Closed	-$358K	–	2463
2021 Q2	$358K	Buy	26,710 +12,238	+85%	+$301K	﹤0.01%	1258
2021 Q1	$742K	Buy	+14,472	New	+$871K	0.01%	700

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Verition Fund Management's CCXI Position: Q4 2022 in Review

Verition Fund Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 67,549 shares — an estimated $3.49M sold.

Verition Fund Management first reported a position in CCXI in Q1 2021 and held it in 3 quarters. The position peaked at $3.49M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Verition Fund Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Verition Fund Management sold 67,549 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.49M.
Verition Fund Management first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 3 quarters.
Verition Fund Management's ChemoCentryx, Inc. position peaked at $3.49M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.